Evidence map›Paper›PMID 38720889›Full record

ArticleFrontiers in immunology2024

Biological effects of intraoperative radiation therapy: histopathological changes and immunomodulation in breast cancer patients.

Javier I J Orozco, Betsy J Valdez, Chikako Matsuba, Michael P Simanonok, Miquel Ensenyat-Mendez, Judi Anne B Ramiscal, Matthew P Salomon, Yuki Takasumi, Janie G Grumley

Abstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Modulation of HMGB1, PRF1, TRAIL, and M-CSF after TARGIT-IORT in breast-conserving surgery: defining a unique acute immune landscape.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Javier I J OrozcoSaint John's Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, United States.
Betsy J ValdezSaint John's Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, United States.
Chikako MatsubaDepartment of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
Michael P SimanonokCenter for Cardiovascular Analytics, Research and Data Science, Providence Research Network, Portland, OR, United States.
Miquel Ensenyat-MendezCancer Epigenetics Laboratory at the Cancer Cell Biology Group, Institut d'Investigació Sanitària Illes Balears (IdISBa), Palma, Spain.
Judi Anne B RamiscalDepartment of Surgical Oncology, Arrowhead Regional Medical Center & California University of Science and Medicine, Colton, CA, United States.
Matthew P SalomonDepartment of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States.
Yuki TakasumiDepartment of Pathology, Providence Saint John's Health Center, Santa Monica, CA, United States.
Janie G GrumleySaint John's Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Intraoperative radiation therapy (IORT) delivers a single accelerated radiation dose to the breast tumor bed during breast-conserving surgery (BCS). The synergistic biologic effects of simultaneous surgery and radiation remain unclear. This study explores the cellular and molecular changes induced by IORT in the tumor microenvironment and its impact on the immune response modulation. Methods: Patients with hormone receptor (HR)-positive/HER2-negative, ductal carcinoma Results: Squamous metaplasia with atypia was exclusively identified in IORT specimens (63.6%, Conclusion: IORT induces histological changes, including squamous metaplasia with atypia, and elicits molecular alterations associated with immune response and intrinsic apoptotic pathways. The increased abundance of immune-related components in breast tissue exposed to IORT suggests a potential shift towards active immunogenicity, particularly immune-desert tumors like HR-positive/HER2-negative breast cancer.

Indexed as

Breast NeoplasmsCarcinoma, Ductal, BreastAgedDendritic CellsErb-b2 Receptor Tyrosine KinasesGene Expression ProfilingHumansMonocytesReceptors, SteroidT-LymphocytesTumor MicroenvironmentERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesReceptors, Steroidbreast neoplasmsimmune responseintraoperative radiation therapy-IORTsquamous metaplasiatumor microenvironment

Identifiers

PMID38720889
PMCPMC11076837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.